Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors

Author:

Kawahara Takashi1ORCID,Kawai Koji2,Kojima Takahiro1,Nagumo Yoshiyuki1,Sakka Shotarou1,Kandori Shuya1ORCID,Negoro Hiromitsu1,Mathis Bryan J3,Maruo Kazushi4,Miura Koji5,Sakamoto Noriaki6,Shinohara Nobuo7,Yamashita Shinichi8ORCID,Yonemori Kan9,Kishida Takeshi10ORCID,Ukimura Osamu11ORCID,Nishimura Kazuo12ORCID,Kobayashi Yasuyuki13,Nishiyama Hiroyuki1

Affiliation:

1. Department of Urology University of Tsukuba Tsukuba Ibaraki Japan

2. Department of Urology International University of Health and Welfare Narita Chiba Japan

3. International Medical Center University of Tsukuba Affiliated Hospital Tsukuba Ibaraki Japan

4. Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan

5. Tsukuba Clinical Research and Development Organization (T‐CReDO), Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan

6. Department of Pathology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan

7. Department of Urology Hokkaido University Graduate School of Medicine Sapporo Hokkaido Japan

8. Department of Urology Tohoku University Graduate School of Medicine Sendai Miyagi Japan

9. Department of Breast and Medical Oncology National Cancer Center Hospital Chuo‐ku Tokyo Japan

10. Department of Urology Kanagawa Cancer Center Yokohama Kanagawa Japan

11. Department of Urology Kyoto Prefectural University of Medicine Kyoto Kyoto Japan

12. Department of Urology Osaka International Cancer Institute Osaka Osaka Japan

13. Department of Urology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Okayama Japan

Funder

Ono Pharmaceutical

Publisher

Wiley

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3